MUSE Cells Explained: Dr. Joy Kong on Anti-Aging and Stem Cell Therapy
Are MUSE cells the next big shift in regenerative medicine, or are they another stem cell buzzword wrapped in shiny packaging? That is the honest question patients should ask before getting excited. In a video from The Dr. Joy Kong Podcast titled “Anti-Aging, Zero Rejection, and the Future of Stem Cell Therapy,” Dr. Joy Kong […]
REPROCELL Wins MSCRF Award to Advance Hypoimmune iPSC Platforms
What happens when cell therapy needs to reach more patients, but manufacturing and immune compatibility still act like locked gates? That is the tension behind REPROCELL’s new Commercialization Award from the Maryland Stem Cell Research Fund, which will support work on hypoimmune iPSC platforms for clinical applications.1 This is not a flashy promise about a […]
NOVAKnee Program Names Made Scientific as Manufacturer for Living Biologic Knee Replacement
Made Scientific will manufacture Columbia’s NOVAKnee implants for a Phase 1 trial expected in 2028 under FDA oversight.
Leukemia Stem Cells Have Hiding Places. New Research Shows How Treatment Might Flush Them Out
New research shows how leukemia stem cells hide in bone marrow niches and why flushing them out could improve treatment.
Can Aging Muscle Stem Cells Be Recharged? What a New Mouse Study Found
A new mouse study found aging muscle stem cells may be recharged through GLS1 or fatty acids, but human proof is next.
3D-Bioprinted Stem Cell Scaffolds for Bone Repair: What Science Shows So Far
New preclinical research explores 3D-bioprinted stem cell scaffolds for bone repair, but it is not clinic-ready yet.
Stem Cells for Alzheimer’s: What Animal Studies Suggest and Why Human Proof Still Matters
Animal studies suggest MSCs may help Alzheimer’s pathways, but human trials still decide what is real.
Stem-Cell-Derived Dopamine Neurons and Parkinson’s: UCLA’s $9M Environmental Risk Study
UCLA will use stem-cell-derived dopamine neurons to study how pesticides and pollution may affect Parkinson’s risk.
Family-Donor Stem Cells for Epidermolysis Bullosa: Early Trial Results Explained
A pediatric trial reported family-donor MSCs were safe in RDEB and improved symptoms. Here is what the evidence means.
Stem Cell Transplant for MS: What the BEAT-MS Trial Is Testing
The BEAT-MS trial is testing stem cell transplant for treatment-resistant MS. Here is what patients should know.